Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Improved melanoma survival at last! Ipilimumab and a paradigm shift for immunotherapy.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Improved melanoma survival at last! Ipilimumab and a paradigm shift for immunotherapy.
Improved melanoma survival at last! Ipilimumab and a paradigm shift for immunotherapy. Pigment Cell Melanoma Res. 2010 Oct; 23(5):580-1.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Clinical Trials as Topic
Humans
Immunotherapy
Ipilimumab
Melanoma
Skin Neoplasms
authors with profiles
Thomas F. Gajewski